AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2573298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 4605401 — intervention group
Group type: EXPERIMENTAL
Intervention: A2/HK/68 vaccine
Number of subjects: 18524
Study 4605401 — intervention group
Group type: COMPARATOR
Intervention: B/Mass/66 vaccine
Number of subjects: 18524
Study 4605401 — intervention group
Group type: COMPARATOR
Intervention: Bivalent vaccine (B/Mass/66 and A2/Mtl/68)
Number of subjects: 18524
Study 4605401 — intervention group
Group type: COMPARATOR
Intervention: Standard aqueous killed bivalent vaccine
Number of subjects: 18524
Study 4605401 — intervention group
Group type: COMPARATOR
Intervention: Zonally-purified vaccines
Number of subjects: 18524
Study 31000205 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dimensional treatment planning
Number of subjects: 57
Study 31000205 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dimensional treatment planning
Number of subjects: 57
Study 31000205 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalometric measurement of accuracy in the anterior maxilla
Number of subjects: 57
Study 31000205 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related quality of life (HRQoL)
Number of subjects: 57
Study 28764729 — intervention group
Group type: EXPERIMENTAL
Intervention: NWpG‐IC
Number of subjects: 511
Study 28764729 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 511
Study 26374833 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoacid supplementation (12 tablets per day)
Number of subjects: 100
Study 23482644 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA‐BN 10(7) TCID50
Number of subjects: 24
Study 23482644 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA‐BN 10(8) TCID50
Number of subjects: 24
Study 23482644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21525519 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (0.25-0.5 mmol/l), n = 24
Number of subjects: 45
Study 21525519 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n = 21
Number of subjects: 45
Study 19252768 — intervention group
Group type: EXPERIMENTAL
Intervention: Periarterial infiltration of 3-5 ml of saline around scalp arteries
Number of subjects: 40
Study 19252768 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration around only the superficial temporal arteries
Number of subjects: 40
Study 17076867 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted education with CoaguChek device
Number of subjects: 0
Study 17076867 — intervention group
Group type: COMPARATOR
Intervention: Multifaceted education without CoaguChek device
Number of subjects: 0
Study 17076867 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 15521369 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of rofecoxib
Number of subjects: 60
Study 15521369 — intervention group
Group type: COMPARATOR
Intervention: Aspirin challenge
Number of subjects: 60
Study 11220879 — intervention group
Group type: EXPERIMENTAL
Intervention: ST + losartan
Number of subjects: 91
Study 11220879 — intervention group
Group type: EXPERIMENTAL
Intervention: ST + losartan + aldactone
Number of subjects: 91
Study 11220879 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (ST)
Number of subjects: 91
Study 9117826 — intervention group
Group type: EXPERIMENTAL
Intervention: Crab collagenase
Number of subjects: 21
Study 9117826 — intervention group
Group type: COMPARATOR
Intervention: Trypsin/chymotrypsin
Number of subjects: 21
Study 1492862 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergocristine (DHEC) 6 mg once daily
Number of subjects: 10
Study 1492862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 4023162 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-androgen combined preparation
Number of subjects: 53
Study 4023162 — intervention group
Group type: COMPARATOR
Intervention: Estrogen-alone drug
Number of subjects: 53
Study 4023162 — intervention group
Group type: COMPARATOR
Intervention: Androgen-alone drug
Number of subjects: 53
Study 4023162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 28705451 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal, noninhaled CO2 (n=19)
Number of subjects: 56
Study 28705451 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=13)
Number of subjects: 56
Study 27755279 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) treatment
Number of subjects: 97
Study 27755279 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 97
Study 27755279 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) treatment after switch from TAU
Number of subjects: 97
Study 25011544 — intervention group
Group type: EXPERIMENTAL
Intervention: REAC technology pulse (250 milliseconds)
Number of subjects: 33
Study 25011544 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 33
Study 23683464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilator response (BDR) test with a cutoff of 12%
Number of subjects: 1291
Study 23683464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilator response (BDR) test with a cutoff of less than 8%
Number of subjects: 1291
Study 20949229 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP (noninvasive ventilation)
Number of subjects: 18
Study 20949229 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy (control group)
Number of subjects: 18
Study 20949229 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BiPAP and standard oxygen therapy)
Number of subjects: 18
Study 18571914 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walking Test (ISWT) with supplementary oxygen
Number of subjects: 41
Study 18571914 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Shuttle Walking Test (ESWT) with supplementary oxygen
Number of subjects: 41
Study 18571914 — intervention group
Group type: COMPARATOR
Intervention: Incremental Shuttle Walking Test (ISWT) with air cylinder
Number of subjects: 41
Study 18571914 — intervention group
Group type: COMPARATOR
Intervention: Endurance Shuttle Walking Test (ESWT) with air cylinder
Number of subjects: 41
Study 18571914 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of percentage change between oxygen and air for responders
Number of subjects: 41
Study 17011446 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous accelerated irradiation (CAIR) 7 days a week
Number of subjects: 100
Study 17011446 — intervention group
Group type: COMPARATOR
Intervention: Conventional 5 days a week (control)
Number of subjects: 100
Study 12860355 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐repeat allele of the DRD4 exon III polymorphism
Number of subjects: 145
Study 12860355 — intervention group
Group type: EXPERIMENTAL
Intervention: T,T genotype of the DRD4 ‐521 C>T polymorphism
Number of subjects: 145
Study 12860355 — intervention group
Group type: EXPERIMENTAL
Intervention: Gly9,Gly9 genotype of the DRD3 Ser9Gly polymorphism
Number of subjects: 145
Study 10432885 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine needle aspiration biopsy (FNAB)
Number of subjects: 32
Study 10432885 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopy
Number of subjects: 32
Study 7721604 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk Factor Education (RFE)
Number of subjects: 0
Study 7721604 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Counseling (BC)
Number of subjects: 0
Study 7721604 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Counseling plus Incentives (BCI)
Number of subjects: 0
Study 2383302 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (Kaveri)
Number of subjects: 10
Study 2383302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6770498 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis (oral nonabsorbed antibiotics)
Number of subjects: 0
Study 6770498 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral administration of antibiotics
Number of subjects: 0
Study 30957578 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 600 mg
Number of subjects: 100
Study 30957578 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid 250 mg
Number of subjects: 100
Study 30957578 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ALA and mefenamic acid
Number of subjects: 100
Study 30957578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 25254433 — intervention group
Group type: EXPERIMENTAL
Intervention: Counter-moralising messages
Number of subjects: 0
Study 25254433 — intervention group
Group type: COMPARATOR
Intervention: Moralising messages
Number of subjects: 0
Study 23577272 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS at 0.8 mA
Number of subjects: 14
Study 23577272 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS at 1.0 mA
Number of subjects: 14
Study 23577272 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS at 1.2 mA
Number of subjects: 14
Study 23577272 — intervention group
Group type: COMPARATOR
Intervention: Control (no tDCS)
Number of subjects: 14
Study 22146249 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular free-end removable partial dentures (RPDs)
Number of subjects: 40
Study 22146249 — intervention group
Group type: COMPARATOR
Intervention: Not wearing RPDs
Number of subjects: 40
Study 22146249 — intervention group
Group type: COMPARATOR
Intervention: Complete dentition
Number of subjects: 40
Study 19860932 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal Lithotomy (DL) position
Number of subjects: 98
Study 19860932 — intervention group
Group type: COMPARATOR
Intervention: Dorsal Lithotomy with Same Side Leg Extended (DLEL) position
Number of subjects: 98
Study 16498052 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF) - 0.5 g fat/kg body weight (BW) per day for 2.5 days
Number of subjects: 11
Study 16498052 — intervention group
Group type: COMPARATOR
Intervention: High-fat diet (HF) - 0.5 g fat/kg BW per day for 1 day followed by 3.5 g fat/kg BW per day for 1.5 days
Number of subjects: 11
Study 15007562 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow injection (15 ml) at the fracture site and casting
Number of subjects: 40
Study 15007562 — intervention group
Group type: COMPARATOR
Intervention: Conventional casting
Number of subjects: 40
Study 12495798 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone in a controlled drinking program (NTX+CD)
Number of subjects: 30
Study 12495798 — intervention group
Group type: COMPARATOR
Intervention: Controlled drinking program alone (CD)
Number of subjects: 30
Study 9836064 — intervention group
Group type: EXPERIMENTAL
Intervention: Panicogenic doses of caffeine administered to PD patients
Number of subjects: 19
Study 9836064 — intervention group
Group type: COMPARATOR
Intervention: Panicogenic doses of caffeine administered to healthy volunteers
Number of subjects: 19
Study 7659767 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (2-mg pieces, up to 30 per day) with reinforcement of lottery tickets for CO < 10 ppm
Number of subjects: 49
Study 7659767 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette Self Report (CSR) with reinforcement for reporting no smoking that day
Number of subjects: 49
Study 7659767 — intervention group
Group type: COMPARATOR
Intervention: Non-contingent payments (Control group)
Number of subjects: 49
Study 2757892 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromakalim (0.01‐10.0 micrograms min‐1)
Number of subjects: 8
Study 2757892 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromakalim (0.001‐1.0 microgram min‐1)
Number of subjects: 8
Study 2757892 — intervention group
Group type: COMPARATOR
Intervention: Glyceryl trinitrate (0.4 microgram min‐1)
Number of subjects: 8
Study 1244406 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Training
Number of subjects: 40
Study 1244406 — intervention group
Group type: EXPERIMENTAL
Intervention: General Training
Number of subjects: 40
Study 1244406 — intervention group
Group type: COMPARATOR
Intervention: No Feedback Training
Number of subjects: 40
Study 1244406 — intervention group
Group type: COMPARATOR
Intervention: No Training
Number of subjects: 40
Study 6807878 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg erythromycin ethyl succinate intramuscularly
Number of subjects: 30
Study 6807878 — intervention group
Group type: COMPARATOR
Intervention: 500 mg erythromycin stearate orally
Number of subjects: 30
Study 30885685 — intervention group
Group type: EXPERIMENTAL
Intervention: AG10 400 mg
Number of subjects: 49
Study 30885685 — intervention group
Group type: EXPERIMENTAL
Intervention: AG10 800 mg
Number of subjects: 49
Study 30885685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 29935541 — intervention group
Group type: EXPERIMENTAL
Intervention: 5As eLearning program for obesity management
Number of subjects: 0
Study 29935541 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment as usual + training of the GP (intervention group)
Number of subjects: 0
Study 29935541 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study 26024926 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol‐electrolyte oral solution (PEG‐EOS)
Number of subjects: 313
Study 26024926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium picosulphate (SS)
Number of subjects: 313
Study 26024926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium biphosphonate (SP)
Number of subjects: 313
Study 26024926 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐EOS with added flavour
Number of subjects: 313
Study 25144598 — intervention group
Group type: EXPERIMENTAL
Intervention: Airflow (4.8 m/s) during exercise
Number of subjects: 10
Study 25144598 — intervention group
Group type: EXPERIMENTAL
Intervention: Precooling (chest-deep immersion at 24 °C for 1 hour or until core temperature dropped 0.5 °C)
Number of subjects: 10
Study 25144598 — intervention group
Group type: COMPARATOR
Intervention: No precooling or airflow (control)
Number of subjects: 10
Study 23089439 — intervention group
Group type: EXPERIMENTAL
Intervention: Incision and drainage
Number of subjects: 64
Study 23089439 — intervention group
Group type: COMPARATOR
Intervention: Needle aspiration
Number of subjects: 64
Study 19879713 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-strength medical compression stockings (MCS)
Number of subjects: 55
Study 19879713 — intervention group
Group type: COMPARATOR
Intervention: Traditional bandages
Number of subjects: 55
Study 17391226 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture-mediated vascular closure device
Number of subjects: 40
Study 17391226 — intervention group
Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 40
Study 17391226 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 15784495 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous radiologic gastrostomy
Number of subjects: 60
Study 15784495 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric tube
Number of subjects: 60
Study 12396159 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 70
Study 10456303 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouchel procedure
Number of subjects: 287
Study 10456303 — intervention group
Group type: EXPERIMENTAL
Intervention: Small slings
Number of subjects: 287
Study 10456303 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacron
Number of subjects: 287
Study 10456303 — intervention group
Group type: EXPERIMENTAL
Intervention: Gore Tex
Number of subjects: 287
Study 7872321 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromagen (ferrous fumarate)
Number of subjects: 46
Study 7872321 — intervention group
Group type: EXPERIMENTAL
Intervention: Feosol (ferrous sulfate)
Number of subjects: 46
Study 7872321 — intervention group
Group type: EXPERIMENTAL
Intervention: Niferex (polysaccharide)
Number of subjects: 46
Study 2193839 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide/amiloride (20 mg frusemide/2.5 mg amiloride daily)
Number of subjects: 18
Study 2193839 — intervention group
Group type: COMPARATOR
Intervention: Bumetanide/potassium chloride (0.5 mg bumetanide/573 mg potassium chloride daily)
Number of subjects: 18
Study 574221 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa with benserazide
Number of subjects: 49
Study 574221 — intervention group
Group type: COMPARATOR
Intervention: Levodopa with carbidopa
Number of subjects: 49
Study 30580092 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 15491
Study 30580092 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 15491
Study 30580092 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (clopidogrel and low-dose aspirin)
Number of subjects: 15491
Study 28162017 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand files
Number of subjects: 135
Study 28162017 — intervention group
Group type: COMPARATOR
Intervention: ProTaper universal retreatment (PTUR) instruments
Number of subjects: 135
Study 28162017 — intervention group
Group type: COMPARATOR
Intervention: Reciproc instruments
Number of subjects: 135
Study 25834336 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-remifentanil (DR)
Number of subjects: 59
Study 25834336 — intervention group
Group type: COMPARATOR
Intervention: Propofol-remifentanil (PR)
Number of subjects: 59
Study 24028650 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake assessment using a validated food-frequency questionnaire
Number of subjects: 4983
Study 24028650 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate linear regression analysis
Number of subjects: 4983
Study 24028650 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 4983
Study 22076086 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 repetition maximum (3RM) back squats
Number of subjects: 9
Study 19994684 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and ginger-partition moxibustion
Number of subjects: 75
Study 19994684 — intervention group
Group type: COMPARATOR
Intervention: Routine western medicine (Metoprolol, Propafenone, Aspirin)
Number of subjects: 75
Study 17876009 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered stress management training
Number of subjects: 310
Study 17876009 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 310
Study 15562063 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard introduction to a Drager Fabius GS anesthesia delivery machine plus simulated clinical use of the new machine in a high-fidelity human patient simulator (HPS)
Number of subjects: 15
Study 15562063 — intervention group
Group type: COMPARATOR
Intervention: Standard introduction alone
Number of subjects: 15
Study 11727735 — intervention group
Group type: EXPERIMENTAL
Intervention: Trinam (1 x 10^11 viral particles, single administration)
Number of subjects: 210
Study 11727735 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 210
Study 9201495 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy, home-dwelling persons aged 65-70 years
Number of subjects: 837
Study 9201495 — intervention group
Group type: EXPERIMENTAL
Intervention: Oldest age groups (cataract operations)
Number of subjects: 837
Study 9201495 — intervention group
Group type: EXPERIMENTAL
Intervention: Oldest age groups (hip prosthesis operations)
Number of subjects: 837
Study 9201495 — intervention group
Group type: EXPERIMENTAL
Intervention: Oldest age groups (coronary by-pass operations)
Number of subjects: 837
Study 9201495 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with comorbidity and institutionalization
Number of subjects: 837
Study 9201495 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who smoke
Number of subjects: 837
Study 9201495 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly patients with moderate signs of dementia (cataract)
Number of subjects: 837
Study 7506187 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide 800mg daily
Number of subjects: 16
Study 7506187 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide 400mg daily
Number of subjects: 16
Study 7506187 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide 600mg daily
Number of subjects: 16
Study 7506187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 7506187 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide 200mg daily
Number of subjects: 16
Study 7506187 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide 300mg daily
Number of subjects: 16
Study 2882234 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal adrenaline
Number of subjects: 12
Study 2882234 — intervention group
Group type: COMPARATOR
Intervention: Peripheral intravenous adrenaline
Number of subjects: 12
Study 31626317 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 61
Study 31626317 — intervention group
Group type: COMPARATOR
Intervention: No ART
Number of subjects: 61
Study 28889834 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA24-Kids-2014 dietary recalls
Number of subjects: 30
Study 28889834 — intervention group
Group type: COMPARATOR
Intervention: Interviewer-administered dietary recalls
Number of subjects: 30
Study 25310993 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose Lupron Depot (22.5 mg leuprolide acetate)
Number of subjects: 109
Study 25310993 — intervention group
Group type: COMPARATOR
Intervention: Low dose Lupron Depot (11.25 mg leuprolide acetate)
Number of subjects: 109
Study 25310993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 23452187 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG induction therapy or BCG induction plus maintenance
Number of subjects: 971
Study 23452187 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance BCG
Number of subjects: 971
Study 23452187 — intervention group
Group type: COMPARATOR
Intervention: Intravesical chemotherapy
Number of subjects: 971
Study 23452187 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG maintenance therapy
Number of subjects: 971
Study 21212378 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal exercise testing
Number of subjects: 23
Study 21212378 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal exercise testing
Number of subjects: 23